Teracyte Analytics

Digitizing Biological Processes

Health Tech & Life Sciences
Active
Seed Caesarea Founded 2020
Total raised
$1.5M
Last: Seed 2022-01
Stage
Seed
Founded
2020
Headcount
19
HQ
Caesarea
Sector
Health Tech & Life Sciences

About

TeraCyte developed a platform for high throughput temporal analysis of live single-cells, based on proprietary array chips, an imaging system and analytical tools. The platform allows for capturing and retaining suspension cells in dedicated cell arrays and real-time monitoring of cell function with high sensitivity fluorescent imaging and a matching high resolution brightfield image.

TeraCyte’s AI models can distinguish between various cell types, count cells and identify cell-cell interactions. TeraCyte’s solution can be used for discovery, development and manufacturing of cell therapies, biological and small molecule drugs. TeraCyte is currently set to begin collaborations with cell therapy companies on the development of high value applications.

Funding history · 1 round · $1.5M total

2022-01
Seed $1.5M

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Teracyte Analytics' primary focus?
Teracyte Analytics developed a platform for high-throughput temporal analysis of live single-cells, utilizing proprietary array chips, an imaging system, and analytical tools.
When was Teracyte Analytics founded?
Teracyte Analytics was founded in March 2020.
How much funding has Teracyte Analytics raised in total?
Teracyte Analytics has raised a total of $1,500,000 in funding.
Which organization invested in Teracyte Analytics' Seed round?
In January 2022, Teracyte Analytics received Seed funding from the Israel Innovation Authority.
What is the current employee count for Teracyte Analytics?
Teracyte Analytics currently has 19 employees.
What is the primary sector of Teracyte Analytics?
Teracyte Analytics' primary sector is Health Tech & Life Sciences.
What technologies does Teracyte Analytics utilize in its platform?
Teracyte Analytics' platform incorporates Simulation & Imaging, Semiconductors & Electronics, Chipsets, and Artificial Intelligence technologies.
Who are the founders of Teracyte Analytics?
The founders of Teracyte Analytics are Yoav Nissan-cohen and Gal Lenz.
What is the current product stage of Teracyte Analytics?
Teracyte Analytics' product is currently in the beta stage.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Simulation & ImagingSemiconductors & ElectronicsChipsetsArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B

Tags

drug-developmentpredictive-analyticspharmaceuticalscellsbiotechnologycell-therapy